EUVIMEDEUVIMED entdecken
Crossref

Perillaldehyde (PAE) Regulates Ovarian Cancer by Modulating HSP70 and Regulating the PI3K/AKT Signaling Pathway

Zhitong Liu, Zhengpeng Xu

Archives of Biochemistry and Biophysics · 2026-11 · 111058

DOI: 10.1016/j.abb.2026.111058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2026-11. Verfasst von Zhitong Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Gynecology, Yantai Yuhuangding Hospital, No. 20, Yudong Road, Zhifu District, Yantai City, Shandong Province, 264000, China. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Perillaldehyde (PAE), a major active component of Perilla frutescens, possesses potential anti-tumor activity. However, its effects and mechanisms in ovarian cancer remain unclear. This study aimed to investigate the impact of PAE on ovarian cancer cells and a subcutaneous xenograft model, and explore the possible mechanisms involved. METHODS: The effects of PAE on proliferation, migration, and invasion of SKOV3 and A2780 cells were assessed using CCK-8, colony formation, EdU, wound healing, and Transwell assays. Expression levels of HSP70, EMT-related proteins (E-cadherin, Vimentin, N-cadherin, MMP2/9), and PI3K/AKT pathway proteins were detected by Western blot. The role of HSP70 was validated by shRNA knockdown and plasmid overexpression. A nude mouse xenograft model was established to evaluate the in vivo anti-tumor effect. RESULTS: PAE reduced cell viability, colony number, and EdU-positive cells in a concentration-dependent manner. PAE downregulated HSP70, Vimentin, N-cadherin, MMP2/9, decreased the ratios of p-PI3K/PI3K and p-AKT/AKT, while upregulating E-cadherin. HSP70 knockdown enhanced these effects, whereas overexpression weakened them. In vivo, PAE decreased tumor volume and weight, reduced Ki67-positive cells, and increased necrotic areas; protein changes were consistent with cell experiments. CONCLUSION: PAE inhibits proliferation, migration, and invasion of ovarian cancer cells and slows tumor growth. The mechanism may involve HSP70 downregulation, PI3K/AKT inhibition, and EMT reversal, providing evidence for PAE as a candidate anti-ovarian cancer agent.

Schlagwörter

Stichwörter der Autor:innen

Epithelial-mesenchymal transition (EMT)Heat shock protein 70 (HSP70)Ovarian cancerPI3K/AKT signaling pathwayPerillaldehyde (PAE)

Autor:innen und Institutionen

  • Gynecology, Yantai Yuhuangding Hospital, No. 20, Yudong Road, Zhifu District, Yantai City, Shandong Province, 264000, China.
  • Obstetrics and Gynecology, Yantai Hospital of Traditional Chinese Medicine, No. 39, Xingfu Road, Zhifu District, Yantai City, Shandong Province, 264001, China. Electronic address: 15053586874@163.com.

Zitieren

APA

Liu, Z., & Xu, Z. (2026). Perillaldehyde (PAE) Regulates Ovarian Cancer by Modulating HSP70 and Regulating the PI3K/AKT Signaling Pathway. Archives of Biochemistry and Biophysics, 111058. https://doi.org/10.1016/j.abb.2026.111058

Vancouver

Liu Z, Xu Z. Perillaldehyde (PAE) Regulates Ovarian Cancer by Modulating HSP70 and Regulating the PI3K/AKT Signaling Pathway. Archives of Biochemistry and Biophysics. 2026:111058. doi:10.1016/j.abb.2026.111058

BibTeX
@article{Liu2026,
  author = {Liu, Zhitong and Xu, Zhengpeng},
  title = {Perillaldehyde (PAE) Regulates Ovarian Cancer by Modulating HSP70 and Regulating the PI3K/AKT Signaling Pathway},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2026},
  pages = {111058},
  doi = {10.1016/j.abb.2026.111058}
}
Kostenlos starten →